Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

Nobel Biocare Holding AG

+ Add to Watchlist

NOBN:SW

17.300 CHF 0.150 0.87%

As of 11:43:41 ET on 03/03/2015.

Snapshot for Nobel Biocare Holding AG (NOBN)

Open: 17.100 Day's Range: 17.100 - 17.300 Volume: 11,482
Previous Close: 17.150 52wk Range: 11.850 - 18.450 1-Yr Rtn: +41.14%

Stock Chart for NOBN

No chart data available.
  • NOBN:SW 17.300
  • 1D
  • 1M
  • 1Y
17.150
Interactive NOBN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NOBN

Current P/E Ratio (ttm) 37.4632
Estimated P/E(12/2014) 37.3052
Relative P/E vs. SMI 2.0155
Earnings Per Share (EUR) (ttm) 0.4300
Est. EPS (EUR) (12/2014) 0.4310
Est. PEG Ratio 2.6124
Market Cap (M CHF) 2,141.47
Shares Outstanding (M) 123.78
30 Day Average Volume 20,120
Price/Book (mrq) 5.6889
Price/Sale (ttm) 3.4909
Dividend Indicated Gross Yield 1.16%
Cash Dividend (CHF) 0.2000
Dividend Ex-Date 03/28/2014
5 Year Dividend Growth -18.32%
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NOBN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for NOBN

Nobel Biocare Holding AG develops and produces dental implants and dental prosthetics. The Company manufactures permanent replacements for tooth roots, and dental crowns and bridges. Nobel Biocare sells under the brand names Branemark System, Steri-Oss/Replace, and Procera on the global market.

Richard T LaubeChief Executive OfficerTullio Di DioChief Financial Officer
Hans GeiselhoringerExec VP:Global ResearchMelker NilssonExec VP:Global Customer
More Company Profile & Key Executives for NOBN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil